Literature DB >> 8374679

Growth and sexual maturation in children with insulin-dependent diabetes mellitus.

J I Malone1.   

Abstract

Prediabetes, the interval preceding the clinical recognition of diabetes mellitus, is believed to consist of several months or years of beta-cell destruction associated with no clinically recognized signs other than possible increased growth velocity. This increased growth rate may be the result of increased insulin, increased growth hormone, or both. As insulin-dependent diabetes approaches clinical recognition, insulin deficiency becomes manifest as slowing of growth velocity and more obvious weight loss. If a prepubertal child has insulin-dependent diabetes mellitus, sexual maturation is frequently delayed and physical growth is adversely affected. Insulin is an anabolic hormone that regulates metabolic pathways involved in the production of protein, glycogen, and fat. The normal release of growth hormone and the hepatic production of insulin-like growth factor I is modulated by the action of insulin. The absence of physiologic insulin response leads to dysfunctional quantities of growth hormone, insulin-like growth factor I, and sex hormones, resulting in growth impairment and delayed sexual maturation. Delayed sexual maturation may cause concern because it has a major impact on growth and maturation of children. However, there is evidence that sex hormones have a stimulating effect on the tissue damage associated with chronic hyperglycemia. The loss of physiologic insulin release significantly affects physical growth, sexual maturation, and the chronic complications associated with insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374679     DOI: 10.1097/00008480-199308000-00021

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes.

Authors:  Kirstie K Danielson; Mari Palta; Catherine Allen; Donn J D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

2.  Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.

Authors:  L R Salgado; M Semer; M Nery; M Knoepfelmacher; A C Lerário; G Póvoa; S Jana; S M Villares; B L Wajchenberg; B Liberman; W Nicolau
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

3.  Secular trends in growth in diabetes: are we winning?

Authors:  K C Donaghue; O Kordonouri; A Chan; M Silink
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

4.  A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes.

Authors:  Y Altuntas
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.